Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Hematopoietic and Lymphoid Cell Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Hematopoietic and Lymphoid Cell Neoplasm

Cancer Family

Hematopoietic and Lymphoid Cell Neoplasm

CI-CAN-00000023Explore in graph →

HematologicNon-malignant4,231 active trials98 approved drugs1,009 evidence items

NCIt: C27134
DOID: 2531
MeSH: D019337

Overview
Statistics
Survival
Genomics60
Variants & evidence1009
Drugs99
Trials18680
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (735)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 601–625 of 735 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.
· J Clin Oncol · 2017 · PMID 27870571 · validated civic_curation pubmed
Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.
· EBioMedicine · 2016 · PMID 27428428 · validated civic_curation pubmed
Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan.
· Blood Cancer J · 2016 · PMID 27176795 · validated civic_curation pubmed
B-Cell Precursor-Acute Lymphoblastic Leukemia With EBF1-PDGFRB Fusion Treated With Hematopoietic Stem Cell Transplantation and Imatinib: A Case Report and Literature Review.
· J Pediatr Hematol Oncol · 2021 · PMID 32068648 · validated civic_curation pubmed
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
· Eur J Haematol · 2019 · PMID 30725494 · validated civic_curation pubmed
The t(1;9)(p34;q34) fusing ABL1 with SFPQ, a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias.
· Leuk Res · 2011 · PMID 21388681 · validated civic_curation pubmed
SFPQ-ABL1-positive B-cell precursor acute lymphoblastic leukemias.
· Genes Chromosomes Cancer · 2020 · PMID 32306475 · validated

Showing 601–625 of 735 publications

← Previous
1
…
24
25
26
…
30
Next →

civic_curation

t(1;9)(p34;q34)/SFPQ-ABL1 Fusion in a Patient with Ph-Like Common B-Cell Acute Lymphoblastic Leukemia.

· Acta Haematol · 2017 · PMID 27894117 · validated civic_curation pubmed

A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34).

· Haematologica · 2009 · PMID 19794096 · validated civic_curation pubmed

RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations.

· Int J Hematol · 2011 · PMID 21863287 · validated civic_curation pubmed

Acute lymphoblastic leukemia associated with RCSD1-ABL1 novel fusion gene has a distinct gene expression profile from BCR-ABL1 fusion.

· Leukemia · 2013 · PMID 23168614 · validated civic_curation pubmed

Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1-positive acute lymphoblastic leukemia.

· Haematologica · 2017 · PMID 28057740 · validated civic_curation pubmed

Cryptic ETV6-ABL1 Fusion and MLL2 Truncation Revealed by Integrative Clinical Sequencing in Multiply Relapsed Acute Lymphoblastic Leukemia.

· J Pediatr Hematol Oncol · 2019 · PMID 30028819 · validated civic_curation pubmed

Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.

· Blood Cancer J · 2015 · PMID 25768406 · validated civic_curation pubmed

Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements.

· Blood · 2019 · PMID 31434701 · validated civic_curation pubmed

Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.

· Blood Adv · 2019 · PMID 31648321 · validated civic_curation pubmed

FISH identifies a KAT6A/CREBBP fusion caused by a cryptic insertional t(8;16) in a case of spontaneously remitting congenital acute myeloid leukemia with a normal karyotype.

· Pediatr Blood Cancer · 2017 · PMID 28097792 · validated civic_curation pubmed

Molecular characteristic of acute leukemias with t(16;21)/FUS-ERG.

· Ann Hematol · 2018 · PMID 29427188 · validated civic_curation pubmed

Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion.

· Front Oncol · 2020 · PMID 32266142 · validated civic_curation pubmed

Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma.

· Genes (Basel) · 2020 · PMID 32668764 · validated civic_curation pubmed

Unusual PDGFRB fusion reveals novel mechanism of kinase activation in Ph-like B-ALL.

· Leukemia · 2023 · PMID 36810896 · validated civic_curation pubmed

Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.

· Leukemia · 2014 · PMID 25212276 · validated civic_curation pubmed

Crizotinib in refractory ALK-positive diffuse large B-cell lymphoma: a case report with a short-term response.

· Eur J Haematol · 2014 · PMID 24330038 · validated civic_curation pubmed

Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response.

· Oncotarget · 2014 · PMID 25015329 · validated civic_curation pubmed

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

· Mol Genet Genomic Med · 2015 · PMID 25802883 · validated civic_curation pubmed